Roger Song's
Stock Forecasts
5.88%
1/17 win trades
Price targets by Roger Song
| Company name & ticker | Publish date | Price target | Price when posted | Source | Historical targets |
|---|---|---|---|---|---|
 Replimune Group, Inc. REPL | 11 months ago | $19 261.21% upside | $14.48 | StreetInsider | Previous targets (0) |
 Aclaris Therapeutics, Inc. ACRS | 12 months ago | $7 300% upside | $3.14 | StreetInsider | Previous targets (0) |
 Corvus Pharmaceuticals, Inc. CRVS | 12 months ago | $13 152.91% upside | $3.97 | StreetInsider | Previous targets (0) |
 Vaxcyte, Inc. PCVX | about 1 year ago | $146 360.13% upside | $106.74 | StreetInsider | |
 Viking Therapeutics, Inc. VKTX | about 1 year ago | $110 350.81% upside | $63.14 | StreetInsider | Previous targets (0) |
 Disc Medicine, Inc. IRON | about 1 year ago | $89 52.97% upside | $50.92 | StreetInsider | Previous targets (0) |
 Novavax, Inc. NVAX | about 1 year ago | $25 163.92% upside | $10.15 | StreetInsider | |
 Nurix Therapeutics, Inc. NRIX | about 1 year ago | $41 314.56% upside | $23.04 | Benzinga | Previous targets (0) |
 Kiniksa Pharmaceuticals, Ltd. KNSA | about 1 year ago | $40 21.21% upside | $24.49 | StreetInsider | Previous targets (0) |
 CytomX Therapeutics, Inc. CTMX | over 1 year ago | $8 299.98% upside | $4.46 | TheFly | |
 Nuvalent, Inc. NUVL | over 1 year ago | $97 29.33% upside | $64.75 | StreetInsider | Previous targets (0) |
 LAVA Therapeutics N.V. LVTX | over 1 year ago | $6 292.15% upside | $3.07 | StreetInsider | Previous targets (0) |
 Tourmaline Bio, Inc. TRML | over 1 year ago | $72 221.85% upside | $44.67 | StreetInsider | Previous targets (0) |
Other analysts covering same stocks
Charles Duncan
Cantor Fitzgerald
40%
win rate
Vernon Bernardino
H.C. Wainwright
25%
win rate
Christopher Liu
Leerink Partners
25%
win rate